1. Stocks
  2. Teva- Pharmaceutical Industries Ltd. - ADR
  3. Swot
swot-logo

Teva- Pharmaceutical Industries Ltd. - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Teva- Pharmaceutical Industries Ltd. - ADR has 8 Strengths, 16 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years - Nifty500

Relative Outperformance versus Industry over 1 Week

Stocks with Consistent Share Price Growth (subscription)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Increasing profits every quarter for the past 2 quarters

Stock with Low PE (PE < = 10)

Stocks with Quarter Change % less than Industry

Momentum Trap (DVM)

Companies with High Debt

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Risky Value (DVM)

Low durability companies

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Top Losers

Companies with Increasing Debt

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Declining Net Cash Flow : Companies not able to generate net cash

Book Value Per Share deteriorating for last 2 years

Weak Momentum: Price below Short, Medium and Long Term Averages

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks